Catalys Pacific — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Pathalyspathalys.comin𝕏Aug 2024 · $105M
Pathalys Pharma is a private biopharmaceutical company developing treatments for kidney disease, including upacicalcet, which is in late-stage development.
BiotechHealthtechResearch Triangle Park, US
Co-investorsOrbiMedSamsara BioCapitalAbingworthKB Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.